Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
DTC
OPDP Sends “Bad Ad” Warning Letter over PARAGARD Video
On February 12, 2021, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent a…
GAO Report Finds DTC Advertising May Lead to Increased Medicare Spend
Senators Chuck Grassley and Dick Durbin asked the Government Accountability Office (GAO) to review the relationship between…
Federal Trade Commission (FTC) Annual Report: Sets Their Sites on Life…
The Federal Trade Commission (“FTC”) recently released its annual report for 2019. The FTC’s annual report details the FTC’s…
DC Circuit Court Holds HHS DTC Disclosure Rule Not Permissible
On June 16, 2020, a unanimous panel of the District of Columbia Circuit Court ruled that a rule finalized by the United States…
Pharmaceutical Manufacturers Weigh-In on OPDP Study of Drug Cancer Ads
The US Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) announced a study of oncology…
FTC Warns Law Firms About Potentially Deceptive Claims in TV Ads
The Federal Trade Commission (“FTC”) sent letters to several law firms and marketing companies, warning them that advertisements…
UK PMCPA Cites Several Pharma Manufacturers for Misleading Ads
Following a review of pharmaceutical advertising, the UK’s Prescription Medicines Code of Practice Authority (“PMCPA”) cited…
FDA Issues Enforcement Letter Regarding Eskata Risks Omitted From DTC…
The US Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) recently issued an enforcement letter…
FDA Issues Advertising Warning Letter to Vivus
The FDA’s Office of Prescription Drug Promotion (OPDP) issued its second untitled letter of the year to California drugmaker Vivus…
FDA to Study Accelerated Approval Drug DTC Marketing
The US Food and Drug Administration (“FDA”) recently published a notice in the Federal Register seeking to find out more about how…